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Depression in and within schizophrenia in
common
21-80%
Prevalence

• 7 to 70%
• Wide range reflects how
schizophrenia and depression was
diagnosed

Epidemiology

ECA patients meeting
DSM III criteria for
schizophrenia were 14
to 28.5 times more likely
to have a concurrent
major depressive
syndrome than general
population

In NCS ,59% of patients
with schizophrenia met
DSM III R criteria for
major or minor
depression

Presentation and Nature of Depression
as Syndrome in the clinical course
Co-existing co morbid depression & dysthiamia
• As major depressive
episode
• As frank manic episode
Longitudinal
• As mixed states
course
• As dysphoric states
• As masked depression or
somatized
• As suicidality

Schizo-affective
Schizomanic
Schizo-obsessive
Schizophrenia
spectrum
Major mood
disorder
Bipolar disorder

“It is increasingly becoming clear that we can not
distinguish satisfactorily between these two illness
and this brings home the suspicion that our
formulation of problem may be incorrect”
Kraepelin .E.

schizophrenia

Affective
Disorder

Historical Phenomenological and
diagnostic dilemma

Affective symptoms as integral part of
schizophrenia across its course

Positive
symptom
Domain

Affective
symptom
Domain

Negative
Symptom
Domain

Cognitive
Symptom
Domain

Emergence of new diagnosis:
Jacob kasonin 1933
The Third
Psychosis:
Schizoaffective
Disorders

Affective
Disorder

Schizophrenia

Clinical overlap of schizophrenia spectrum and bipolar
spectrum disorder

Current issues on schizoaffective disorder
Encephale. 2005

• Research on schizoaffective disorder has
been marred by the variability of its
definition.
• Further studies are however still necessary,
especially with regard to the subtyping of
the disorder and its pharmacological
treatment.

Are schizophrenia and affective
disorder related? 2007
 The Kraepelinian view of psychoses

may need modification.

Best evidence of depression in Schizophrenia and
Correlation with of Neuroleptics comes from
epidemiology
( Johnson, 1981,Hirsch 1989,Hirsch 1973)

Depression occurs across the course of
schizophrenia

‘Diagnostic Validity of Schizoaffective disorders’
Shrivastava A, Rao, S. IJP.1997

Current Evidence

Population
Prevalence

Related
Symptom
Cluster

Common neurobiological origin of
‘Severe’ psychosis”

3-4%

Bipolar
Spectrum

Bipolar Disorder: type I

2%

Depressive
spectrum

Unipolar
Depression with
psychotic features

0.7-1.4%

Schizophrenia
spectrum

Schizophrenia

0.5-0.7%

Genotype

Environmental
unmasking

Multiple
disease
phenotypes

An Endophenotype of Schizophrenia

Environm
ental
Susceptib
ility Gene

Psychologi
cal
Unmaskin
g

Social
Unmasking

Modifier
Genes
Behavioral
TraitsCorrelates

Life style
issue

Schizophrenia
spectrum

Risk factors

Genotype
Brain
Vulnerabil
ity
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Etiological
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Continuum of genetic liability to psychotic illness

Increasing neurodevelopmental impairment

Increasing genetic liability

Neuroendocrine:
Evidence for a neuromodulatory role for TRH
CSF thyrotropin-releasing hormone concentrations differ in patients with
schizoaffective disorder from patients with schizophrenia or mood disorders, :
Charles B. Nemeroffc Journal of Psychiatric Research
Volume 35, Issue 5, September-October 2001,

Does schizoaffective disorder really exist?
middle point of a continuum between SCH and MD.
J Affect Disord. 2008 Mar
Schizoaffective disorder merges schizophrenia and bipolar disorders as one
disease-

there is no schizoaffective disorder

-

Curr Opin Psychiatry. 2007 Jul;.

Schizoaffective disorders are psychotic mood
disorders; there are no schizoaffective disorders.
Psychiatry Res. 2006 Aug

Insight
Depression

The
Evidence

Why does depression occur in schizophrenia: Neurobiology

Depression in schizophrenia:. MRI and PET
findings. Biol Psychiatry. 1998
The high depression group had larger bilateral
temporal lobe volumes and decreased laterality
(left minus right of metabolism in the anterior
cingulate).

Depression-suicide & Schizophrenia

↑
↑
↑
↑

frequency & duration of hospitalization2
risk of suicide3
risk of relapse3
impairment in social
roles & relationships3
• ↑ unemployment4
•
•
•
•

Burden of Illness of Comorbid Depression in
Schizophrenia
Depression in schizophrenia associated with lower
QoL (n=67)1

Treatment Choice and Phase of illness

Current evidence: Anti Depressant Drugs
Use of antidepressant drugs in schizophrenic patients with depression
Encephale. 2006

• The results provide weak evidence for the efficacy of
antidepressants in patients with schizophrenia and
depression.
• the only SSRI tested in the treatment of depression in
schizophrenic patients is sertraline.
• In meta-analysis, No difference between the 2 treatment
groups was demonstrated

Current evidence : Mood Stabilizers
•
•
•
•
•
•
•

Lithium
Carbamezapine
Valproic acid
Lamotregene
Toperamate
Gabapentine
Calcium channel
blockers

Are atypical neuroleptics
mood stabilisers?
• Are they effective beyond psychotic
affective states?
• Are they effective against the depressive
phase of bipolar disorder?
• Do they induce mania?
• Do they work in mixed states?
• Do they work in rapid cycling?
• Can they prevent suicide?

5 HT System in the Brain

Depression in schizophrenia : perspective in era of ‘atypical antipsychotics’. Siris ,S.G.AJP 2000 ;157

How do we explain?
Why do Atypical antipsychotics have Antidepressant action?
A: Regional distribution of 5-HT System in the Brain??

• Optimizing antipsychotic treatment and atypical antipsychotics
prove to be most effective
• Adjunctive antidepressants may be useful for patients who are
not acutely ill
• Careful longitudinal assessment is required to ensure
identification of primary mood disorders

Relative Efficacy of AAPD for mood symptoms
and suicidality in Schizophrenia
•
•
•
•
•
•
•
•

Clozapine
Olanzapine
Aripiprazole
Quetiapine
Amisulpiride
Ziprasidone
Paliperidone
Risperidone

Increasing
efficacy

CATIE outcome of Mood symptoms

Does quetiapine have mood altering
properties?
• The data indicate that a side-effect of quetiapine may
be mood elevation.
• An ability to elevate mood while controlling
psychoses would be helpful in the treatment of postpsychotic and bipolar depression.
• Its clinical importance in the control of manic
episodes, for which atypical antipsychotics are used
increasingly, is uncertain.

Schizophrenia with associated complications:
Dysphoria

McEvoy JP. Journal of Clinical Psychiatry 1999;60(11):1-80.

Schizophrenia with associated complications:
Suicidal behavior

McEvoy JP. Journal of Clinical Psychiatry 1999;60(11):1-80.

6-wk, open-label study in patients with schizoaffective
disorder, bipolar type (n=102)
HAM-D change

YMRS change

MADRS change

p=0.010

1. Kinon et al. J Clin Psychopharm 2006;26:157-62.

24-week, RCT in patients with
schizophrenia or schizoaffective disorder
with depressive symptoms (n=394)
CDSS change

p=0.105

CDSS: Calgary Depression Scale for Schizophrenia
MADRS: Montgomery-Asberg Depression Rating
Scale

Atypical Antipsychotics: Improvement
in Depressive Symptoms
12-week, naturalistic, observational study
Depression
Anxiety

HAM-D: Hamilton Rating Scale for Depression;
HAM-A: Hamilton Rating Scale for Anxiety

1. Strous et al. Hum Psychopharm 2006;21:235-43.

Quetiapine
Switching Antipsychotics May Improve
Depressive Symptoms
Subgroup with clinically significant depressive symptoms at baseline

* p ≤0.001

CDSS score ≤6 represents
NO clinical depression

CDSS: Calgary Depression Scale for Schizophrenia

1. De Nayer et al. Int J Psych Clin Pract 2003;7:59-66.

SPECTRUM, 12-wk, open trial in
patients with schizophrenia
switched to quetiapine (n=509)

Current evidence : ECT
J ECT. 2006 Jun;22(2):127-32.

Role of Adjunctive Therapies for Mood
Symptoms.
• Schizoaffective disorder
– Lithium: little evidence of benefit for
manic type
– Antidepressants: Antipsychotic + AD
equal or less effective than
antipsychotic alone
– Anticonvulsants: No evidence of benefit

1. Levinson et al. Am J Psychiatry 1999;156:113848.

–Antidepressants2,3
•Acutely: no advantage of
antipsychotic + AD vs.
antipsychotic alone
•Post-psychotic MDD:
adjunctive AD may be useful

• Optimizing antipsychotic
treatment is likely a more
effective strategy for mood
symptoms
1. Leucht et al. J Clin Psychiatry 2004;65:177-86. 2. Levinson et
al. Am J Psychiatry 1999;156:1138-48. 3. Whitehead et al.
Cochrane Database Syst Rev 2002:CD002305.

Psychosocial Interventions in
Schizophrenia
 Proven effective adjuncts to
pharmacotherapy1
 Social skills training
 Cognitive remediation
 Psychoeducational coping-oriented interventions
with families & relatives
 Cognitive behavioural therapy

1. Pfammatter et al. Schizophr Bull 2006;32 Suppl 1:S64-80. 2. Jaeger et al. Aust N Z J Psychiatry
2006;40:452-61. 3. Lysaker et al. J Rehabil Res Dev 2005;42:673-82. 4. Pitschel-Walz et al. J Clin
Psychiatry 2006;67:443-52.

Comprehensive Treatment Programs

 Specialized early intervention approach can

provide:1,2

 ↑ short-term clinical and functional outcomes
 ↑ retention in treatment
 ↓ relapse rates
 ↑ satisfaction with service delivery
 ↑ greater family involvement
 ↑ QoL
1. Malla et al. Can J Psychiatry 2005;50:881-91. 2. Harvey et al. Can J
Psychiatry 2007;52:464-72.

Future Classification of mental
disorders: Hypothesis: From
1933 to 2008

Why does suicide occur in psychosis?

What is clinical relevance of this context?
Evidence for occurrence of depression
before suicide attempt
1.Biological findings
2.Psychological theories
3. Epidemiological findings
4.Postmartum studies
5.Post-vention studies
There is evidence
Of depressed mood
In 98% subjects who
Successfully kill themselves

Prevention of Suicide in Psychotic Disorders:
General principles and strategies.
Term ‘Discharge’ is a misnomer.
It is actually ‘transfer of Care from Hospital to Community’
It is a dynamic Process’ .
It is just a mile stones on Continuous spectrum of care

Review: Assessment, Outcome, Care
Plan, Discharge Plan, Risk
Management & Transfer of care

Documentation

Prevention of Suicide in Psychotic Disorders: General principles
and strategies.

Prevention of Suicide in Psychotic Disorders: General
principles and strategies.

Conclusions:
Schizoaffective disorders.
There are many unanswered questions

• Mood symptoms are common, responsive and severe.
• Schizoaffective disorder is a severe psychotic disorder with
disability, burden and complications.
• Schizoaffective Disorder is an inconsistent condition and does
not deserve an independent diagnosis
• We are moving towards unitary theory for single-severepsychotic-disorder, based on clinical and biological evidences
• Treatment appears inadequate and unclear, but optimizing
atypicals APD appears best option.
• Clozapine has a special efficacy.

